DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
B••••• H•••••
H•••••care & Pharmaceuticalsgroup grade Aoff every schedule since Dec 31, 2024sponsor unattributed
Also written as: B••••• H••••• Companies Inc
Nothing material in the last 200 days. Last change: 31 Dec 2024, Consensus mark 104¢ on cost, up from 79¢ a year ago, 103¢ last quarter.
Mark path, consensus per quarter end
79¢ · 87¢ · 99¢ · 103¢ · 104¢Q2 2023 to Q4 2024
Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
$167M
n/a on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
0
1 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Jun 30, 2023
latest Dec 31, 2024
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Dec 31, 2024, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A••••• D••• S•••••••• B•• | no principal filed | 104¢ | +1 pts |
| M••••• F•••••••• I••••••••• C••• | no principal filed | 104¢ | +1 pts |
Every BDC piece · 3 positions across 2 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A••••• D••• S•••••••• B•• | unstated lien unstated | Not disclosed | $151M 104c | |
| M••••• F•••••••• I••••••••• C••• | unstated lien unstated | Not disclosed | $8.1M 104c | |
| M••••• F•••••••• I••••••••• C••• | unstated lien unstated | Not disclosed | $8.1M 104c |
Capital structure as the BDCs see it
latest quarter end Dec 31, 2024
No debt facility on the tape for this borrower; the BDC pieces are equity.
Equity pieces beside the debt: other ($167M fair value, 2 BDCs)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2 | $0 | $0 | n/a | 0 |
| Sep 30, 2024 | 2 | $0 | $0 | n/a | 0 |
| Jun 30, 2024 | 1 | $0 | $0 | n/a | 0 |
| Sep 30, 2023 | 1 | $0 | $0 | n/a | 0 |
All 5 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2023 | 1 | $0 | $0 | n/a | 0 |
What changed
- New borrower on a BDC scheduleJun 30, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- B••••• H•••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- H•••••care & Pharmaceuticalsreportedas one filer wrote it